

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | opioid receptor signaling pathway (GO:0038003) | 8.10063049 |
| 2 | negative regulation of cAMP-mediated signaling (GO:0043951) | 7.65071097 |
| 3 | pattern specification involved in kidney development (GO:0061004) | 7.59768779 |
| 4 | behavioral response to ethanol (GO:0048149) | 7.32655666 |
| 5 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 7.08894413 |
| 6 | ether lipid metabolic process (GO:0046485) | 6.79071211 |
| 7 | regulation of translational termination (GO:0006449) | 6.41338618 |
| 8 | drug transmembrane transport (GO:0006855) | 6.35599540 |
| 9 | adult feeding behavior (GO:0008343) | 6.26104792 |
| 10 | imidazole-containing compound metabolic process (GO:0052803) | 6.17689312 |
| 11 | response to pheromone (GO:0019236) | 5.89840833 |
| 12 | regulation of protein glycosylation (GO:0060049) | 5.77575552 |
| 13 | keratinocyte development (GO:0003334) | 5.71837220 |
| 14 | cellular response to electrical stimulus (GO:0071257) | 5.67136862 |
| 15 | regulation of keratinocyte proliferation (GO:0010837) | 5.32478677 |
| 16 | piRNA metabolic process (GO:0034587) | 4.83299980 |
| 17 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.69826751 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.64873073 |
| 19 | sphingosine metabolic process (GO:0006670) | 4.45935874 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33681058 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.29043607 |
| 22 | mRNA cleavage (GO:0006379) | 4.28280064 |
| 23 | cellular response to ammonium ion (GO:0071242) | 4.26908110 |
| 24 | head development (GO:0060322) | 4.19503587 |
| 25 | diol metabolic process (GO:0034311) | 4.18459241 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.15704315 |
| 27 | positive regulation of synapse maturation (GO:0090129) | 4.10728311 |
| 28 | negative regulation of telomerase activity (GO:0051974) | 4.06993294 |
| 29 | dopamine biosynthetic process (GO:0042416) | 4.06396584 |
| 30 | presynaptic membrane organization (GO:0097090) | 4.04099318 |
| 31 | interferon-gamma production (GO:0032609) | 4.00185773 |
| 32 | cornea development in camera-type eye (GO:0061303) | 4.00171083 |
| 33 | sphingoid metabolic process (GO:0046519) | 3.93394486 |
| 34 | glomerular visceral epithelial cell development (GO:0072015) | 3.88903147 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 3.86521952 |
| 36 | notochord development (GO:0030903) | 3.86217673 |
| 37 | positive regulation of calcium ion import (GO:0090280) | 3.85111376 |
| 38 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.83792101 |
| 39 | drug transport (GO:0015893) | 3.82339224 |
| 40 | proximal/distal pattern formation (GO:0009954) | 3.77683602 |
| 41 | telomere maintenance via telomerase (GO:0007004) | 3.77192410 |
| 42 | glycerol ether metabolic process (GO:0006662) | 3.75085643 |
| 43 | regulation of synapse maturation (GO:0090128) | 3.73957354 |
| 44 | dicarboxylic acid catabolic process (GO:0043649) | 3.70756232 |
| 45 | ncRNA catabolic process (GO:0034661) | 3.70653414 |
| 46 | auditory behavior (GO:0031223) | 3.67791818 |
| 47 | peripheral nervous system neuron development (GO:0048935) | 3.67080759 |
| 48 | coenzyme catabolic process (GO:0009109) | 3.66683568 |
| 49 | membrane depolarization during action potential (GO:0086010) | 3.65546373 |
| 50 | righting reflex (GO:0060013) | 3.62882375 |
| 51 | pyrimidine dimer repair (GO:0006290) | 3.62117833 |
| 52 | regulation of interleukin-5 production (GO:0032674) | 3.61636439 |
| 53 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.61589355 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.61589355 |
| 55 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.59515890 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.59056957 |
| 57 | nucleobase catabolic process (GO:0046113) | 3.56845975 |
| 58 | regulation of megakaryocyte differentiation (GO:0045652) | 3.52214936 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.50774519 |
| 60 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.48442741 |
| 61 | ether metabolic process (GO:0018904) | 3.44713685 |
| 62 | startle response (GO:0001964) | 3.43589943 |
| 63 | protein neddylation (GO:0045116) | 3.42310251 |
| 64 | gamma-aminobutyric acid transport (GO:0015812) | 3.38917905 |
| 65 | regulation of translational elongation (GO:0006448) | 3.35804252 |
| 66 | glomerular epithelial cell development (GO:0072310) | 3.35072541 |
| 67 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.32937333 |
| 68 | catecholamine biosynthetic process (GO:0042423) | 3.31863560 |
| 69 | catechol-containing compound biosynthetic process (GO:0009713) | 3.31863560 |
| 70 | cAMP catabolic process (GO:0006198) | 3.31734813 |
| 71 | neuronal action potential propagation (GO:0019227) | 3.29893818 |
| 72 | establishment of mitochondrion localization (GO:0051654) | 3.27413620 |
| 73 | replication fork processing (GO:0031297) | 3.24542701 |
| 74 | presynaptic membrane assembly (GO:0097105) | 3.24260738 |
| 75 | neuronal action potential (GO:0019228) | 3.22992755 |
| 76 | single strand break repair (GO:0000012) | 3.19369892 |
| 77 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18493288 |
| 78 | response to methylmercury (GO:0051597) | 3.13280308 |
| 79 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.11173492 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09425633 |
| 81 | eyelid development in camera-type eye (GO:0061029) | 3.08244460 |
| 82 | amyloid precursor protein catabolic process (GO:0042987) | 3.07730186 |
| 83 | superoxide anion generation (GO:0042554) | 3.05424213 |
| 84 | proline transport (GO:0015824) | 3.05238343 |
| 85 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.05131757 |
| 86 | mitochondrion transport along microtubule (GO:0047497) | 3.05131757 |
| 87 | regulation of cAMP-mediated signaling (GO:0043949) | 3.04552380 |
| 88 | mechanosensory behavior (GO:0007638) | 3.03114680 |
| 89 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.01418771 |
| 90 | acrosome reaction (GO:0007340) | 3.00557542 |
| 91 | thrombin receptor signaling pathway (GO:0070493) | 3.00013182 |
| 92 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.99489922 |
| 93 | postsynaptic membrane organization (GO:0001941) | 2.98465436 |
| 94 | vocalization behavior (GO:0071625) | 2.97014946 |
| 95 | response to caffeine (GO:0031000) | 2.96538855 |
| 96 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.94420051 |
| 97 | negative regulation of cyclase activity (GO:0031280) | 2.93048940 |
| 98 | neuron-neuron synaptic transmission (GO:0007270) | 2.92316227 |
| 99 | glycosphingolipid metabolic process (GO:0006687) | 2.90995227 |
| 100 | ephrin receptor signaling pathway (GO:0048013) | 2.89498237 |
| 101 | negative regulation of lyase activity (GO:0051350) | 2.87812787 |
| 102 | cyclic nucleotide catabolic process (GO:0009214) | 2.86395214 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 2.86043933 |
| 104 | atrial cardiac muscle cell action potential (GO:0086014) | 2.84469606 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83847448 |
| 106 | epithelial cilium movement (GO:0003351) | 2.83166839 |
| 107 | monoamine transport (GO:0015844) | 2.82440909 |
| 108 | regulation of calcium ion import (GO:0090279) | 2.82093251 |
| 109 | segment specification (GO:0007379) | 2.81408156 |
| 110 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.81030316 |
| 111 | lung epithelium development (GO:0060428) | 2.80951953 |
| 112 | protein localization to synapse (GO:0035418) | 2.80020276 |
| 113 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.79525090 |
| 114 | brain morphogenesis (GO:0048854) | 2.79259224 |
| 115 | eosinophil migration (GO:0072677) | 2.78650684 |
| 116 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.78008155 |
| 117 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.77948936 |
| 118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.76762714 |
| 119 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75659471 |
| 120 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75659471 |
| 121 | positive regulation of interleukin-4 production (GO:0032753) | 2.75429245 |
| 122 | metanephric nephron tubule development (GO:0072234) | 2.75319050 |
| 123 | metanephric tubule development (GO:0072170) | 2.75319050 |
| 124 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.72941306 |
| 125 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.71112741 |
| 126 | bile acid biosynthetic process (GO:0006699) | 2.70920524 |
| 127 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.68173249 |
| 128 | sympathetic nervous system development (GO:0048485) | 2.68139176 |
| 129 | peptide catabolic process (GO:0043171) | 2.67499069 |
| 130 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.66920689 |
| 131 | DNA synthesis involved in DNA repair (GO:0000731) | 2.66653577 |
| 132 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.66311848 |
| 133 | negative regulation of interleukin-10 production (GO:0032693) | 2.65219149 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.65099585 |
| 135 | cellular response to alkaloid (GO:0071312) | 2.64797300 |
| 136 | neuron cell-cell adhesion (GO:0007158) | 2.60935853 |
| 137 | regulation of dopamine metabolic process (GO:0042053) | 2.57885774 |
| 138 | regulation of catecholamine metabolic process (GO:0042069) | 2.57885774 |
| 139 | regulation of telomerase activity (GO:0051972) | 2.54966246 |
| 140 | multicellular organism reproduction (GO:0032504) | 2.54474254 |
| 141 | hair follicle development (GO:0001942) | 2.54199948 |
| 142 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.53753695 |
| 143 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53408962 |
| 144 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.53398225 |
| 145 | glycosylceramide metabolic process (GO:0006677) | 2.53058877 |
| 146 | response to auditory stimulus (GO:0010996) | 2.51172614 |
| 147 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.51055414 |
| 148 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.51055414 |
| 149 | sperm motility (GO:0030317) | 2.50688939 |
| 150 | neutrophil activation (GO:0042119) | 2.50289699 |
| 151 | sensory perception of pain (GO:0019233) | 2.49552005 |
| 152 | neuron recognition (GO:0008038) | 2.49527719 |
| 153 | rhodopsin mediated signaling pathway (GO:0016056) | 2.49165441 |
| 154 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.49107381 |
| 155 | positive regulation of fibroblast migration (GO:0010763) | 2.48854013 |
| 156 | regulation of somitogenesis (GO:0014807) | 2.48523912 |
| 157 | RNA-dependent DNA replication (GO:0006278) | 2.48136079 |
| 158 | calcium ion import (GO:0070509) | 2.47727314 |
| 159 | neuronal ion channel clustering (GO:0045161) | 2.47609768 |
| 160 | retinal metabolic process (GO:0042574) | 2.47293777 |
| 161 | spermatid development (GO:0007286) | 2.47100358 |
| 162 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.46952198 |
| 163 | resolution of meiotic recombination intermediates (GO:0000712) | 2.46747152 |
| 164 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.46533555 |
| 165 | phenol-containing compound catabolic process (GO:0019336) | 2.46510896 |
| 166 | ketone body metabolic process (GO:1902224) | 2.45856202 |
| 167 | negative regulation of cAMP metabolic process (GO:0030815) | 2.45826232 |
| 168 | cilium morphogenesis (GO:0060271) | 2.45770358 |
| 169 | meiotic chromosome segregation (GO:0045132) | 2.45679461 |
| 170 | amine biosynthetic process (GO:0009309) | 2.45258077 |
| 171 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.45258077 |
| 172 | limb bud formation (GO:0060174) | 2.44690834 |
| 173 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44158067 |
| 174 | skeletal muscle organ development (GO:0060538) | 2.43816162 |
| 175 | glycine transport (GO:0015816) | 2.43570685 |
| 176 | L-amino acid import (GO:0043092) | 2.42683824 |
| 177 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.41937297 |
| 178 | focal adhesion assembly (GO:0048041) | 2.41854129 |
| 179 | cell-substrate adherens junction assembly (GO:0007045) | 2.41854129 |
| 180 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.41775835 |
| 181 | receptor recycling (GO:0001881) | 2.41497627 |
| 182 | response to epinephrine (GO:0071871) | 2.41393767 |
| 183 | androgen biosynthetic process (GO:0006702) | 2.41255721 |
| 184 | specification of organ identity (GO:0010092) | 2.39808079 |
| 185 | negative regulation of cell aging (GO:0090344) | 2.38750082 |
| 186 | myeloid dendritic cell differentiation (GO:0043011) | 2.38094697 |
| 187 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.37971450 |
| 188 | membrane lipid metabolic process (GO:0006643) | 2.36375757 |
| 189 | metanephric nephron epithelium development (GO:0072243) | 2.34205510 |
| 190 | layer formation in cerebral cortex (GO:0021819) | 2.33769640 |
| 191 | regulation of actin filament-based movement (GO:1903115) | 2.33708278 |
| 192 | synaptic vesicle exocytosis (GO:0016079) | 2.33321269 |
| 193 | negative regulation of osteoblast proliferation (GO:0033689) | 2.31773670 |
| 194 | positive regulation of granulocyte differentiation (GO:0030854) | 2.30004470 |
| 195 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 10.7546926 |
| 196 | negative regulation of keratinocyte proliferation (GO:0010839) | 10.6431428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.85714585 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.45716058 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21395411 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.20127873 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.91861537 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84701573 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.70820393 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51185767 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.45029480 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.44405872 |
| 11 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.38266020 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36622021 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.35563273 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34853224 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26846221 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.24417333 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23454494 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22833220 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22833220 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20448146 |
| 21 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19988107 |
| 22 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.19988107 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18804401 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17613514 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09391599 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07905915 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.07133017 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98487722 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98475273 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92860416 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92039902 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.90995848 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83985799 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82318533 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79884275 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.79545175 |
| 37 | RXR_22108803_ChIP-Seq_LS180_Human | 1.79408493 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.77442189 |
| 39 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.77442189 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73692196 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72415072 |
| 42 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.70688831 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70421318 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70389264 |
| 45 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.69176905 |
| 46 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.68887905 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66725376 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65809608 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65489396 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64340042 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61501815 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57957296 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.56552551 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56176296 |
| 55 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.55635289 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51543018 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.51373962 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.51373962 |
| 59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.50562673 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50050234 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49903029 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49654272 |
| 63 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.49099353 |
| 64 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.49030247 |
| 65 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.48417025 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47566031 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45156644 |
| 68 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.44000325 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43946200 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43170436 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41169143 |
| 72 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.41139387 |
| 73 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.40501043 |
| 74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.40388838 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.38468893 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37627061 |
| 77 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.36369102 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36102772 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33887652 |
| 80 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.33637147 |
| 81 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.32847812 |
| 82 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.32821210 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30739656 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30678803 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30576431 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29699652 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29026672 |
| 88 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.28772008 |
| 89 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.28713034 |
| 90 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.28395465 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27447054 |
| 92 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27416539 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27015749 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26675520 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24211331 |
| 96 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23668886 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22830354 |
| 98 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22651174 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22024516 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21930111 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.21542914 |
| 102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21186968 |
| 103 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19983444 |
| 104 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.17656450 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16064797 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14553164 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14381156 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14293418 |
| 109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13217673 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12823626 |
| 111 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12447536 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12064875 |
| 113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11815702 |
| 114 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10420360 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09716079 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09694503 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09122999 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08647452 |
| 119 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.08277472 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07813660 |
| 121 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07538891 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05853464 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05733333 |
| 124 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05469727 |
| 125 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05453422 |
| 126 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05057366 |
| 127 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03143312 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01550834 |
| 129 | JUN_21703547_ChIP-Seq_K562_Human | 1.01456921 |
| 130 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01440003 |
| 131 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01107417 |
| 132 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00855434 |
| 133 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00643460 |
| 134 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00233263 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99928910 |
| 136 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99502888 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99010745 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98736595 |
| 139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98310436 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98098421 |
| 141 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98040173 |
| 142 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95862995 |
| 143 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.95728625 |
| 144 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95609631 |
| 145 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95132116 |
| 146 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95099590 |
| 147 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.93348588 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.92949882 |
| 149 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92731677 |
| 150 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92300695 |
| 151 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.92051494 |
| 152 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.91573591 |
| 153 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90937824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005645_abnormal_hypothalamus_physiol | 5.86631574 |
| 2 | MP0005360_urolithiasis | 3.99227414 |
| 3 | MP0004510_myositis | 3.52126328 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.39949687 |
| 5 | MP0003283_abnormal_digestive_organ | 3.35379336 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.22286164 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.21561759 |
| 8 | MP0004885_abnormal_endolymph | 2.99584278 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.92092609 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.76601391 |
| 11 | MP0003011_delayed_dark_adaptation | 2.74800618 |
| 12 | MP0005451_abnormal_body_composition | 2.73193346 |
| 13 | MP0009278_abnormal_bone_marrow | 2.71154244 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.56314450 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.40974597 |
| 16 | MP0004142_abnormal_muscle_tone | 2.35071053 |
| 17 | MP0004270_analgesia | 2.21357541 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.19657125 |
| 19 | MP0000579_abnormal_nail_morphology | 2.13049724 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.07100906 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.03203399 |
| 22 | MP0005171_absent_coat_pigmentation | 2.02157637 |
| 23 | MP0003880_abnormal_central_pattern | 1.94658702 |
| 24 | MP0004133_heterotaxia | 1.90675613 |
| 25 | MP0009053_abnormal_anal_canal | 1.80174930 |
| 26 | MP0003195_calcinosis | 1.77168640 |
| 27 | MP0008057_abnormal_DNA_replication | 1.77079997 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.76845757 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.75314254 |
| 30 | MP0001188_hyperpigmentation | 1.72523664 |
| 31 | MP0001177_atelectasis | 1.68571440 |
| 32 | MP0004147_increased_porphyrin_level | 1.64843914 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.60553804 |
| 34 | MP0009745_abnormal_behavioral_response | 1.60331959 |
| 35 | MP0009046_muscle_twitch | 1.59049278 |
| 36 | MP0002272_abnormal_nervous_system | 1.57015681 |
| 37 | MP0001919_abnormal_reproductive_system | 1.56137567 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.51269447 |
| 39 | MP0002163_abnormal_gland_morphology | 1.51227604 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.50519316 |
| 41 | MP0003879_abnormal_hair_cell | 1.49340795 |
| 42 | MP0008058_abnormal_DNA_repair | 1.47794563 |
| 43 | MP0003938_abnormal_ear_development | 1.47209001 |
| 44 | MP0000681_abnormal_thyroid_gland | 1.47121127 |
| 45 | MP0000778_abnormal_nervous_system | 1.45825420 |
| 46 | MP0001905_abnormal_dopamine_level | 1.45486154 |
| 47 | MP0001664_abnormal_digestion | 1.44879222 |
| 48 | MP0002249_abnormal_larynx_morphology | 1.44868856 |
| 49 | MP0003633_abnormal_nervous_system | 1.44488505 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.43516982 |
| 51 | MP0003868_abnormal_feces_composition | 1.42261782 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.41166264 |
| 53 | MP0010368_abnormal_lymphatic_system | 1.41085541 |
| 54 | MP0002184_abnormal_innervation | 1.40544098 |
| 55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37901274 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.36446185 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.35430322 |
| 58 | MP0004134_abnormal_chest_morphology | 1.34094412 |
| 59 | MP0010678_abnormal_skin_adnexa | 1.31330435 |
| 60 | MP0001764_abnormal_homeostasis | 1.30747598 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.30648288 |
| 62 | MP0000427_abnormal_hair_cycle | 1.30542702 |
| 63 | MP0002295_abnormal_pulmonary_circulatio | 1.29302576 |
| 64 | MP0005379_endocrine/exocrine_gland_phen | 1.28440573 |
| 65 | MP0001486_abnormal_startle_reflex | 1.28097218 |
| 66 | MP0002160_abnormal_reproductive_system | 1.27384048 |
| 67 | MP0002102_abnormal_ear_morphology | 1.23451197 |
| 68 | MP0005253_abnormal_eye_physiology | 1.21800846 |
| 69 | MP0003787_abnormal_imprinting | 1.21068088 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 1.19032988 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 1.16427310 |
| 72 | MP0001970_abnormal_pain_threshold | 1.15969839 |
| 73 | MP0002233_abnormal_nose_morphology | 1.15938980 |
| 74 | MP0002064_seizures | 1.15804420 |
| 75 | MP0003045_fibrosis | 1.14618769 |
| 76 | MP0003123_paternal_imprinting | 1.14287136 |
| 77 | MP0003941_abnormal_skin_development | 1.13097104 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 1.12765432 |
| 79 | MP0004924_abnormal_behavior | 1.11744206 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.11744206 |
| 81 | MP0001984_abnormal_olfaction | 1.11476799 |
| 82 | MP0005423_abnormal_somatic_nervous | 1.10408353 |
| 83 | MP0005195_abnormal_posterior_eye | 1.10202455 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.09781777 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.09149912 |
| 86 | MP0000955_abnormal_spinal_cord | 1.06748048 |
| 87 | MP0002067_abnormal_sensory_capabilities | 1.05366150 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 1.05074168 |
| 89 | MP0003950_abnormal_plasma_membrane | 1.04820349 |
| 90 | MP0002229_neurodegeneration | 1.04726770 |
| 91 | MP0005248_abnormal_Harderian_gland | 1.02748079 |
| 92 | MP0005410_abnormal_fertilization | 1.02655476 |
| 93 | MP0000920_abnormal_myelination | 1.02343560 |
| 94 | MP0002733_abnormal_thermal_nociception | 1.01222070 |
| 95 | MP0003631_nervous_system_phenotype | 1.00717574 |
| 96 | MP0002697_abnormal_eye_size | 0.98972491 |
| 97 | MP0003385_abnormal_body_wall | 0.98972261 |
| 98 | MP0003937_abnormal_limbs/digits/tail_de | 0.98845581 |
| 99 | MP0000762_abnormal_tongue_morphology | 0.98714772 |
| 100 | MP0001270_distended_abdomen | 0.98259948 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.96046147 |
| 102 | MP0001968_abnormal_touch/_nociception | 0.95952849 |
| 103 | MP0005394_taste/olfaction_phenotype | 0.94505866 |
| 104 | MP0005499_abnormal_olfactory_system | 0.94505866 |
| 105 | MP0002736_abnormal_nociception_after | 0.94090024 |
| 106 | MP0005389_reproductive_system_phenotype | 0.93932480 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.92611431 |
| 108 | MP0006276_abnormal_autonomic_nervous | 0.92388306 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.92000156 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.91185214 |
| 111 | MP0000049_abnormal_middle_ear | 0.88931709 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.88405498 |
| 113 | MP0004043_abnormal_pH_regulation | 0.88387317 |
| 114 | MP0008872_abnormal_physiological_respon | 0.87466704 |
| 115 | MP0004811_abnormal_neuron_physiology | 0.87390019 |
| 116 | MP0000749_muscle_degeneration | 0.86825961 |
| 117 | MP0003646_muscle_fatigue | 0.86541875 |
| 118 | MP0001293_anophthalmia | 0.84727372 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.84671885 |
| 120 | MP0009764_decreased_sensitivity_to | 0.84589336 |
| 121 | MP0000026_abnormal_inner_ear | 0.83840595 |
| 122 | MP0008874_decreased_physiological_sensi | 0.83503247 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.83481289 |
| 124 | MP0000358_abnormal_cell_content/ | 0.82670820 |
| 125 | MP0002752_abnormal_somatic_nervous | 0.81081701 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.81022629 |
| 127 | MP0001529_abnormal_vocalization | 0.80968950 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.80631972 |
| 129 | MP0001324_abnormal_eye_pigmentation | 0.80446417 |
| 130 | MP0005646_abnormal_pituitary_gland | 0.79225635 |
| 131 | MP0003698_abnormal_male_reproductive | 0.77683325 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.77494253 |
| 133 | MP0002066_abnormal_motor_capabilities/c | 0.76403374 |
| 134 | MP0006138_congestive_heart_failure | 0.76299540 |
| 135 | MP0002971_abnormal_brown_adipose | 0.76041212 |
| 136 | MP0008260_abnormal_autophagy | 0.75843513 |
| 137 | MP0004085_abnormal_heartbeat | 0.74149280 |
| 138 | MP0002254_reproductive_system_inflammat | 0.73966274 |
| 139 | MP0002234_abnormal_pharynx_morphology | 0.73370726 |
| 140 | MP0004233_abnormal_muscle_weight | 0.73169539 |
| 141 | MP0000639_abnormal_adrenal_gland | 0.70103500 |
| 142 | MP0003718_maternal_effect | 0.69913436 |
| 143 | MP0003252_abnormal_bile_duct | 0.69157114 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.69125504 |
| 145 | MP0005391_vision/eye_phenotype | 0.68986155 |
| 146 | MP0002090_abnormal_vision | 0.68597719 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.68262599 |
| 148 | MP0002282_abnormal_trachea_morphology | 0.68235609 |
| 149 | MP0001340_abnormal_eyelid_morphology | 0.67993634 |
| 150 | MP0003959_abnormal_lean_body | 0.66084269 |
| 151 | MP0010771_integument_phenotype | 0.64982732 |
| 152 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64766516 |
| 153 | MP0002928_abnormal_bile_duct | 0.63518008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged neonatal jaundice (HP:0006579) | 6.83125511 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.73984037 |
| 3 | Volvulus (HP:0002580) | 5.72378314 |
| 4 | Broad alveolar ridges (HP:0000187) | 5.14526072 |
| 5 | Intestinal atresia (HP:0011100) | 4.62970812 |
| 6 | Gastrointestinal stroma tumor (HP:0100723) | 4.58346428 |
| 7 | Decreased central vision (HP:0007663) | 4.46960598 |
| 8 | Absent speech (HP:0001344) | 4.33810286 |
| 9 | Optic nerve hypoplasia (HP:0000609) | 4.29106893 |
| 10 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.97713988 |
| 11 | Cerebellar dysplasia (HP:0007033) | 3.95869572 |
| 12 | Type II lissencephaly (HP:0007260) | 3.93925170 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.86666737 |
| 14 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 3.58069875 |
| 15 | Lissencephaly (HP:0001339) | 3.57585755 |
| 16 | Upper limb muscle weakness (HP:0003484) | 3.47609246 |
| 17 | Aplasia cutis congenita (HP:0001057) | 3.41538250 |
| 18 | Metabolic alkalosis (HP:0200114) | 3.41269933 |
| 19 | Tented upper lip vermilion (HP:0010804) | 3.39212530 |
| 20 | Thickened helices (HP:0000391) | 3.30286036 |
| 21 | Oligodontia (HP:0000677) | 3.27999248 |
| 22 | Retinal dysplasia (HP:0007973) | 3.24732623 |
| 23 | Large for gestational age (HP:0001520) | 3.23170254 |
| 24 | Hypokalemic alkalosis (HP:0001949) | 3.18802031 |
| 25 | Amyloidosis (HP:0011034) | 3.17897326 |
| 26 | Progressive inability to walk (HP:0002505) | 3.13545652 |
| 27 | Tubular atrophy (HP:0000092) | 3.13434503 |
| 28 | Abnormality of the ileum (HP:0001549) | 3.13190853 |
| 29 | Confusion (HP:0001289) | 3.13177775 |
| 30 | Focal seizures (HP:0007359) | 3.11807807 |
| 31 | Status epilepticus (HP:0002133) | 2.98655552 |
| 32 | Agitation (HP:0000713) | 2.96861091 |
| 33 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.95821722 |
| 34 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.95821722 |
| 35 | Broad-based gait (HP:0002136) | 2.94139087 |
| 36 | Increased corneal curvature (HP:0100692) | 2.92524869 |
| 37 | Keratoconus (HP:0000563) | 2.92524869 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.90326157 |
| 39 | Abnormality of macular pigmentation (HP:0008002) | 2.88186293 |
| 40 | Fat malabsorption (HP:0002630) | 2.88112395 |
| 41 | Abnormal hair laboratory examination (HP:0003328) | 2.85030977 |
| 42 | Pendular nystagmus (HP:0012043) | 2.84489352 |
| 43 | Septo-optic dysplasia (HP:0100842) | 2.82847541 |
| 44 | Poor head control (HP:0002421) | 2.80612177 |
| 45 | Neonatal respiratory distress (HP:0002643) | 2.79250361 |
| 46 | Abnormality of the pulmonary veins (HP:0011718) | 2.78923850 |
| 47 | Focal motor seizures (HP:0011153) | 2.78158915 |
| 48 | Chorioretinal coloboma (HP:0000567) | 2.75102374 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.73652037 |
| 50 | Anomalous pulmonary venous return (HP:0010772) | 2.72601384 |
| 51 | Inability to walk (HP:0002540) | 2.70800317 |
| 52 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.70600238 |
| 53 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.69257675 |
| 54 | Sensorimotor neuropathy (HP:0007141) | 2.67458472 |
| 55 | Hyperventilation (HP:0002883) | 2.64766470 |
| 56 | Mesangial abnormality (HP:0001966) | 2.62069974 |
| 57 | White forelock (HP:0002211) | 2.57914622 |
| 58 | Pili torti (HP:0003777) | 2.56144255 |
| 59 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.53897774 |
| 60 | Gastrointestinal atresia (HP:0002589) | 2.52049003 |
| 61 | Cutaneous melanoma (HP:0012056) | 2.50826377 |
| 62 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.50486490 |
| 63 | Chromsome breakage (HP:0040012) | 2.49393820 |
| 64 | Horizontal nystagmus (HP:0000666) | 2.48015956 |
| 65 | Broad nasal tip (HP:0000455) | 2.45172689 |
| 66 | Dialeptic seizures (HP:0011146) | 2.43818574 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.43391809 |
| 68 | Hyperglycinuria (HP:0003108) | 2.38939344 |
| 69 | Large eyes (HP:0001090) | 2.38128430 |
| 70 | Thyroid-stimulating hormone excess (HP:0002925) | 2.35832828 |
| 71 | Restrictive lung disease (HP:0002091) | 2.32598237 |
| 72 | Onion bulb formation (HP:0003383) | 2.31746599 |
| 73 | Fragile nails (HP:0001808) | 2.31014920 |
| 74 | Nasolacrimal duct obstruction (HP:0000579) | 2.25102891 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24008963 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24008963 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24008963 |
| 78 | Carpal bone hypoplasia (HP:0001498) | 2.23734473 |
| 79 | Emphysema (HP:0002097) | 2.23690574 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.23186915 |
| 81 | Pheochromocytoma (HP:0002666) | 2.22976046 |
| 82 | Intellectual disability, moderate (HP:0002342) | 2.21379611 |
| 83 | Ketoacidosis (HP:0001993) | 2.20815213 |
| 84 | Partial duplication of thumb phalanx (HP:0009944) | 2.19547168 |
| 85 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.19077978 |
| 86 | Pachygyria (HP:0001302) | 2.18514005 |
| 87 | Astrocytoma (HP:0009592) | 2.17199214 |
| 88 | Abnormality of the astrocytes (HP:0100707) | 2.17199214 |
| 89 | Abnormality of the alveolar ridges (HP:0006477) | 2.15108256 |
| 90 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14473049 |
| 91 | Abnormality of glycine metabolism (HP:0010895) | 2.14473049 |
| 92 | Mesomelia (HP:0003027) | 2.13467262 |
| 93 | Patchy hypopigmentation of hair (HP:0011365) | 2.13132421 |
| 94 | Pancreatic cysts (HP:0001737) | 2.12701243 |
| 95 | Curly hair (HP:0002212) | 2.12218434 |
| 96 | Broad metatarsal (HP:0001783) | 2.11937121 |
| 97 | Morphological abnormality of the middle ear (HP:0008609) | 2.11780788 |
| 98 | Hip dysplasia (HP:0001385) | 2.10813029 |
| 99 | Attenuation of retinal blood vessels (HP:0007843) | 2.09274569 |
| 100 | Hyperpituitarism (HP:0010514) | 2.07518317 |
| 101 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.07116948 |
| 102 | Aplasia of the phalanges of the hand (HP:0009802) | 2.07116948 |
| 103 | Aplasia involving bones of the extremities (HP:0009825) | 2.07116948 |
| 104 | Severe muscular hypotonia (HP:0006829) | 2.06206497 |
| 105 | Synostosis of carpal bones (HP:0005048) | 2.05817786 |
| 106 | J-shaped sella turcica (HP:0002680) | 2.03365787 |
| 107 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.02497802 |
| 108 | Anophthalmia (HP:0000528) | 2.01958440 |
| 109 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01628427 |
| 110 | Fair hair (HP:0002286) | 2.00414504 |
| 111 | Severe visual impairment (HP:0001141) | 2.00322987 |
| 112 | Abnormality of the fovea (HP:0000493) | 1.99509290 |
| 113 | Myokymia (HP:0002411) | 1.96680820 |
| 114 | Partial duplication of the phalanx of hand (HP:0009999) | 1.96255465 |
| 115 | Renal cortical cysts (HP:0000803) | 1.94256199 |
| 116 | Generalized hypotonia (HP:0001290) | 1.94110497 |
| 117 | Prostate neoplasm (HP:0100787) | 1.93899158 |
| 118 | Visual hallucinations (HP:0002367) | 1.92644591 |
| 119 | Neuroendocrine neoplasm (HP:0100634) | 1.89464627 |
| 120 | Broad ribs (HP:0000885) | 1.89458660 |
| 121 | Truncus arteriosus (HP:0001660) | 1.88161087 |
| 122 | Poikiloderma (HP:0001029) | 1.88136756 |
| 123 | Pulmonary artery stenosis (HP:0004415) | 1.88080537 |
| 124 | Ankyloglossia (HP:0010296) | 1.88062934 |
| 125 | Cortical dysplasia (HP:0002539) | 1.87806983 |
| 126 | Abnormality of the aortic arch (HP:0012303) | 1.87370519 |
| 127 | Fatigue (HP:0012378) | 1.87283492 |
| 128 | Insomnia (HP:0100785) | 1.86877359 |
| 129 | Absent septum pellucidum (HP:0001331) | 1.85867432 |
| 130 | Pancreatic fibrosis (HP:0100732) | 1.85288838 |
| 131 | Ulnar deviation of finger (HP:0009465) | 1.84939193 |
| 132 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.82500351 |
| 133 | Lymphopenia (HP:0001888) | 1.81914605 |
| 134 | Prolonged QT interval (HP:0001657) | 1.80786416 |
| 135 | Supranuclear gaze palsy (HP:0000605) | 1.80720082 |
| 136 | Midline defect of the nose (HP:0004122) | 1.79982503 |
| 137 | Generalized tonic-clonic seizures (HP:0002069) | 1.79472188 |
| 138 | Wrist flexion contracture (HP:0001239) | 1.78846751 |
| 139 | Meningocele (HP:0002435) | 1.78621882 |
| 140 | Fetal akinesia sequence (HP:0001989) | 1.78473792 |
| 141 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76877209 |
| 142 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.76449030 |
| 143 | Lip pit (HP:0100267) | 1.75288411 |
| 144 | Encephalitis (HP:0002383) | 1.74187561 |
| 145 | Narrow nasal bridge (HP:0000446) | 1.73869620 |
| 146 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.73755781 |
| 147 | Atonic seizures (HP:0010819) | 1.73360659 |
| 148 | Abnormality of the vitreous humor (HP:0004327) | 1.72901659 |
| 149 | Syncope (HP:0001279) | 1.72295175 |
| 150 | Reticulocytosis (HP:0001923) | 1.72176039 |
| 151 | Prolonged bleeding time (HP:0003010) | 1.71774820 |
| 152 | High anterior hairline (HP:0009890) | 1.71107408 |
| 153 | Epileptic encephalopathy (HP:0200134) | 1.70712883 |
| 154 | Epileptiform EEG discharges (HP:0011182) | 1.69256550 |
| 155 | Bradycardia (HP:0001662) | 1.68698014 |
| 156 | Dysdiadochokinesis (HP:0002075) | 1.68660447 |
| 157 | Amblyopia (HP:0000646) | 1.67180071 |
| 158 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.67169811 |
| 159 | Anterior segment dysgenesis (HP:0007700) | 1.66557258 |
| 160 | True hermaphroditism (HP:0010459) | 1.65481154 |
| 161 | Glioma (HP:0009733) | 1.64953973 |
| 162 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.64123609 |
| 163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.64123609 |
| 164 | Methylmalonic aciduria (HP:0012120) | 1.64001072 |
| 165 | Hypoplasia of the brainstem (HP:0002365) | 1.63907458 |
| 166 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.63907458 |
| 167 | Febrile seizures (HP:0002373) | 1.63816765 |
| 168 | Hypoplasia of the pons (HP:0012110) | 1.59899094 |
| 169 | Drooling (HP:0002307) | 1.59273403 |
| 170 | Hypoalbuminemia (HP:0003073) | 1.58361879 |
| 171 | Abnormal albumin level (HP:0012116) | 1.58361879 |
| 172 | Oligodactyly (hands) (HP:0001180) | 1.57660753 |
| 173 | Ketosis (HP:0001946) | 1.57500204 |
| 174 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.56659405 |
| 175 | Hypoproteinemia (HP:0003075) | 1.55950071 |
| 176 | Meningioma (HP:0002858) | 1.55384483 |
| 177 | Poor speech (HP:0002465) | 1.55061626 |
| 178 | Truncal ataxia (HP:0002078) | 1.54873648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.74177587 |
| 2 | STK38L | 4.89527495 |
| 3 | STK24 | 4.73902629 |
| 4 | PINK1 | 3.98199513 |
| 5 | PNCK | 3.00047136 |
| 6 | BMPR1B | 2.87898967 |
| 7 | CDK12 | 2.65326527 |
| 8 | DYRK3 | 2.23624226 |
| 9 | EPHB2 | 2.22719878 |
| 10 | CAMKK2 | 2.17577780 |
| 11 | MARK1 | 2.15071453 |
| 12 | CASK | 11.3424843 |
| 13 | PIK3CG | 1.88191596 |
| 14 | INSRR | 1.79992868 |
| 15 | TYRO3 | 1.79027049 |
| 16 | IRAK3 | 1.74301088 |
| 17 | LATS1 | 1.70747818 |
| 18 | CSNK1G3 | 1.70009550 |
| 19 | STK16 | 1.68755885 |
| 20 | PDK2 | 1.63007731 |
| 21 | TGFBR1 | 1.61029453 |
| 22 | NTRK3 | 1.55111927 |
| 23 | ACVR1B | 1.53095223 |
| 24 | SRPK1 | 1.52552944 |
| 25 | PRKD2 | 1.52295207 |
| 26 | PRKCG | 1.51402607 |
| 27 | CSNK1A1L | 1.49122372 |
| 28 | EIF2AK2 | 1.44570717 |
| 29 | ADRBK2 | 1.43352092 |
| 30 | CSNK1G1 | 1.38285983 |
| 31 | PRKCE | 1.38258100 |
| 32 | PKN1 | 1.30191142 |
| 33 | CSNK1G2 | 1.28156883 |
| 34 | MAP4K2 | 1.27446796 |
| 35 | CAMK1G | 1.18771041 |
| 36 | EIF2AK3 | 1.18549086 |
| 37 | ERN1 | 1.17697080 |
| 38 | ZAK | 1.13362122 |
| 39 | WNK3 | 1.10288858 |
| 40 | CCNB1 | 1.09099242 |
| 41 | GRK5 | 1.07964090 |
| 42 | STK3 | 1.04677336 |
| 43 | STK11 | 1.03657142 |
| 44 | MAPK13 | 1.02919652 |
| 45 | DYRK2 | 0.97617713 |
| 46 | MST1R | 0.96748948 |
| 47 | CAMK1 | 0.91107043 |
| 48 | ERBB4 | 0.87353810 |
| 49 | PRKCH | 0.85782931 |
| 50 | FGR | 0.85154397 |
| 51 | RET | 0.82922645 |
| 52 | MKNK1 | 0.82007363 |
| 53 | TRIM28 | 0.81784569 |
| 54 | CLK1 | 0.81644495 |
| 55 | PIM1 | 0.81248296 |
| 56 | MINK1 | 0.80766369 |
| 57 | DMPK | 0.80453305 |
| 58 | MUSK | 0.79170541 |
| 59 | STK39 | 0.75525871 |
| 60 | IRAK1 | 0.74848775 |
| 61 | PRPF4B | 0.73959059 |
| 62 | BCR | 0.73801442 |
| 63 | MKNK2 | 0.73491862 |
| 64 | BRSK1 | 0.72833204 |
| 65 | MAP2K7 | 0.71557194 |
| 66 | CDC42BPA | 0.71050047 |
| 67 | CDK5 | 0.69783504 |
| 68 | STK38 | 0.69376808 |
| 69 | PRKCI | 0.69302268 |
| 70 | DYRK1A | 0.68438889 |
| 71 | GRK7 | 0.68061671 |
| 72 | MAP3K6 | 0.67567702 |
| 73 | NEK2 | 0.67339763 |
| 74 | STK10 | 0.67334520 |
| 75 | MAP2K6 | 0.65604579 |
| 76 | OXSR1 | 0.63327541 |
| 77 | WEE1 | 0.62413793 |
| 78 | MAPKAPK5 | 0.61963732 |
| 79 | WNK4 | 0.60992010 |
| 80 | PAK6 | 0.60637082 |
| 81 | SIK2 | 0.59277473 |
| 82 | CAMK2A | 0.58396592 |
| 83 | PHKG1 | 0.57850303 |
| 84 | PHKG2 | 0.57850303 |
| 85 | MYLK | 0.56349872 |
| 86 | ATM | 0.56209226 |
| 87 | TSSK6 | 0.54634833 |
| 88 | NUAK1 | 0.54131724 |
| 89 | MAPK11 | 0.50983725 |
| 90 | CSNK1E | 0.50520715 |
| 91 | EPHA4 | 0.49223856 |
| 92 | TNIK | 0.48305361 |
| 93 | PTK2 | 0.47706178 |
| 94 | TGFBR2 | 0.47326576 |
| 95 | FER | 0.45307843 |
| 96 | MOS | 0.45013505 |
| 97 | BRAF | 0.44695786 |
| 98 | YES1 | 0.42776051 |
| 99 | MAP3K7 | 0.42543890 |
| 100 | PRKG1 | 0.41654952 |
| 101 | BRSK2 | 0.41452490 |
| 102 | MST4 | 0.41076044 |
| 103 | PTK2B | 0.40649052 |
| 104 | MAP3K4 | 0.40518871 |
| 105 | TLK1 | 0.39735104 |
| 106 | FGFR2 | 0.39712430 |
| 107 | PRKAA2 | 0.39358147 |
| 108 | NEK9 | 0.39167670 |
| 109 | PKN2 | 0.38713078 |
| 110 | PRKCB | 0.38360043 |
| 111 | TXK | 0.37852611 |
| 112 | RPS6KA5 | 0.37639301 |
| 113 | CAMKK1 | 0.37619562 |
| 114 | NTRK2 | 0.37145150 |
| 115 | LATS2 | 0.36438075 |
| 116 | KIT | 0.36193057 |
| 117 | RPS6KA3 | 0.35805632 |
| 118 | CDK4 | 0.35590690 |
| 119 | MET | 0.35431997 |
| 120 | CAMK2B | 0.35197959 |
| 121 | PRKAA1 | 0.34180548 |
| 122 | MAPK4 | 0.34007523 |
| 123 | PRKACA | 0.32882171 |
| 124 | PLK2 | 0.31690609 |
| 125 | MARK3 | 0.31472030 |
| 126 | PAK3 | 0.31229115 |
| 127 | MAP2K4 | 0.30373813 |
| 128 | ERBB2 | 0.30364937 |
| 129 | PRKCA | 0.30020633 |
| 130 | CAMK4 | 0.29711026 |
| 131 | SIK3 | 0.29513861 |
| 132 | PRKDC | 0.29381495 |
| 133 | TTK | 0.29155153 |
| 134 | PRKCQ | 0.28200237 |
| 135 | MAP3K14 | 0.27748063 |
| 136 | FLT3 | 0.27529278 |
| 137 | ADRBK1 | 0.27034144 |
| 138 | UHMK1 | 0.26730254 |
| 139 | CAMK2D | 0.25612587 |
| 140 | OBSCN | 0.25538747 |
| 141 | MELK | 0.25168386 |
| 142 | CSNK1D | 0.24821135 |
| 143 | PRKD3 | 0.24653954 |
| 144 | IKBKE | 0.24253088 |
| 145 | IKBKB | 0.24200576 |
| 146 | FES | 0.24121587 |
| 147 | KSR1 | 0.23421655 |
| 148 | PRKACB | 0.21696929 |
| 149 | CDK3 | 0.20602393 |
| 150 | GRK1 | 0.20490081 |
| 151 | ABL1 | 0.20331344 |
| 152 | PLK1 | 0.19974410 |
| 153 | SRC | 0.19903961 |
| 154 | MAP3K13 | 0.19312340 |
| 155 | GRK6 | 0.18982789 |
| 156 | WNK1 | 0.18923020 |
| 157 | CAMK2G | 0.18349984 |
| 158 | CSNK1A1 | 0.18005840 |
| 159 | DAPK2 | 0.17065274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39629507 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.28998579 |
| 3 | Cocaine addiction_Homo sapiens_hsa05030 | 2.71485636 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.65803960 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.56872055 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.41774915 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08571674 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.05541574 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.95634951 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 1.90585648 |
| 11 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.87180742 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86584033 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83054912 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.81912064 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.81005520 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.78786006 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.75272429 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.70971001 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.70282616 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.65356616 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60443988 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58291590 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54672745 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52910363 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.47481649 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43532671 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43166556 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.38223298 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.36483687 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.34313837 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32892402 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.30527339 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.21821966 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19870293 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19846276 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16744225 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15079320 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14980220 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14521737 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.13762048 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11803413 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.11763934 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11614353 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10503490 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.09729072 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.09386635 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07392450 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.04170760 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99587721 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97703329 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96253902 |
| 52 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95189764 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94085108 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.93857111 |
| 55 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.93671453 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93126308 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91118119 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91011433 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89320765 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88240911 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87182534 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.86627600 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86434534 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86295503 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85983901 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85341231 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84739969 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.83401221 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83148248 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82474440 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81393345 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80762458 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.80428259 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79965478 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79456895 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79004336 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78581184 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77759732 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77004984 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76523363 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76062114 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75765030 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74603912 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74049061 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.71650300 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71441911 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70554700 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69281986 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67284805 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.67032112 |
| 91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67031392 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66735094 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66303249 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65565776 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65328511 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65299948 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64440327 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.62842244 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61996209 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61739960 |
| 101 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61546483 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61495407 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60606529 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59873517 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58521116 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57896074 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56099986 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55662604 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52826430 |
| 110 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52824715 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52818060 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51686560 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49212067 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47374781 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47066550 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46729119 |
| 117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46712139 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46673708 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.46447899 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45632541 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.44922678 |
| 122 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43467466 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42415861 |
| 124 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42376818 |
| 125 | Homologous recombination_Homo sapiens_hsa03440 | 0.42311489 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.42127002 |
| 127 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41441538 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40884561 |
| 129 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40810638 |
| 130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40504261 |
| 131 | Bile secretion_Homo sapiens_hsa04976 | 0.39500866 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39372021 |
| 133 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39337094 |
| 134 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38970962 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38029776 |
| 136 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37501627 |
| 137 | Gap junction_Homo sapiens_hsa04540 | 0.37066429 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36373503 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35552911 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35406033 |

